| 000 | 01632 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513084124.0 | ||
| 264 | 0 | _c19960222 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a0146-6615 | ||
| 024 | 7 |
_a10.1002/jmv.1890470316 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPawlotsky, J M | |
| 245 | 0 | 0 |
_aSignificance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. _h[electronic resource] |
| 260 |
_bJournal of medical virology _cNov 1995 |
||
| 300 |
_a285-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDNA Primers |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C _xblood |
| 650 | 0 | 4 |
_aHepatitis C Antibodies _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin M _xblood |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aViral Core Proteins _ximmunology |
| 700 | 1 | _aDarthuy, F | |
| 700 | 1 | _aRémiré, J | |
| 700 | 1 | _aPellet, C | |
| 700 | 1 | _aUdin, L | |
| 700 | 1 | _aStuyver, L | |
| 700 | 1 | _aRoudot-Thoraval, F | |
| 700 | 1 | _aDuvoux, C | |
| 700 | 1 | _aDouvin, C | |
| 700 | 1 | _aMallat, A | |
| 773 | 0 |
_tJournal of medical virology _gvol. 47 _gno. 3 _gp. 285-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmv.1890470316 _zAvailable from publisher's website |
| 999 |
_c8550356 _d8550356 |
||